The Journal of Community and Supportive OncologyHarnessing new data on immunotherapiesJuly 22, 2015Breast CancerGastroenterologyGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaPreventive Care
The Journal of Community and Supportive OncologyA weekly speech and language therapy service for head and neck radiotherapy patients during treatment: maximizing accessibility and efficiencyJuly 22, 2015Head & Neck/Thyroid CancersPatient & Survivor Care
The Journal of Community and Supportive OncologyASCO 2015: from data and learning, to daily practiceJuly 22, 2015Breast CancerGastroenterologyHead & Neck/Thyroid CancersGenitourinary CancerLung CancerPreventive CareMelanoma
Oncology PracticeModerate THST was most effective at treating thyroid cancerJuly 17, 2015Head & Neck/Thyroid CancersRare Diseases
Oncology PracticeNew guidelines focus on pediatric thyroid nodules and cancerJuly 17, 2015PediatricsRare DiseasesHead & Neck/Thyroid Cancers
Oncology PracticeGene-testing predictive value can depend on institutional cancer prevalenceJuly 15, 2015Head & Neck/Thyroid Cancers
Oncology PracticeRAI given to thyroid CA patients does not increase their breast malignancy occurrence, recurrenceJuly 9, 2015Breast CancerHead & Neck/Thyroid Cancers
Oncology PracticeThyroid cancer gene screening questioned for indeterminate nodulesJune 24, 2015Head & Neck/Thyroid Cancers
Oncology PracticeThyroid cancer outcomes worse for black and Hispanic young adultsJune 22, 2015Head & Neck/Thyroid Cancers
Oncology PracticeASA: Mutation testing aids decision making in thyroid cancerJune 3, 2015Rare DiseasesHead & Neck/Thyroid Cancers
Oncology PracticeAACE: How to safely skip radioactive iodine for low-grade thyroid cancerJune 2, 2015Head & Neck/Thyroid Cancers
Oncology PracticeVIDEO: Elective neck dissection during primary surgery improves oral cancer survivalJune 2, 2015Head & Neck/Thyroid CancersRare Diseases
Oncology PracticeUpfront neck dissection boosts oral cancer survivalMay 31, 2015Head & Neck/Thyroid Cancers
Oncology PracticePembrolizumab active in head and neck cancer, regardless of HPV statusMay 30, 2015Head & Neck/Thyroid Cancers
Oncology PracticeOral cancer survival lower with positive margins, public insuranceMay 14, 2015Head & Neck/Thyroid Cancers
